A patient on levothyroxine 50 µg daily has a normal free T4 but a markedly elevated TSH of 54 mIU/L; how should the levothyroxine dose be adjusted?

Increase the levothyroxine dose immediately—a TSH of 54 mIU/L indicates severe undertreatment requiring prompt dose escalation.

With a TSH of 54 mIU/L, you should increase the levothyroxine dose by 25-50 mcg daily, bringing the patient to 75-100 mcg daily, and recheck TSH in 4-8 weeks. This patient is profoundly hypothyroid despite having a normal free T4, which represents inadequate tissue thyroid hormone delivery.

Dose Adjustment Strategy

The current 50 mcg dose is clearly insufficient. According to established guidelines, when TSH is markedly elevated (>12 mIU/L), initial dosing should be at least 75 mcg daily 1. For a TSH as high as 54 mIU/L, the patient requires:

• Immediate increase to 75-100 mcg daily (increment of 25-50 mcg)
• The FDA label supports dose adjustments of 12.5-25 mcg increments 2, but with such severe elevation, a 25-50 mcg increase is appropriate
• Full replacement dosing approximates 1.6 mcg/kg/day 1, which for most adults ranges from 100-150 mcg daily

Critical Evaluation Points Before Dose Increase

Before increasing the dose, you must evaluate for three common causes of apparent treatment failure:

1. Medication adherence - Non-compliance is the most common cause of persistently elevated TSH on adequate doses 1. Directly ask about missed doses and pill-taking habits.

2. Timing of administration - Levothyroxine must be taken 30-60 minutes before breakfast or 4 hours after the last meal on an empty stomach 1. Taking it with food dramatically reduces absorption 1.

3. Interfering substances - Multiple medications and supplements impair levothyroxine absorption including calcium, iron, proton pump inhibitors, and fiber 1. Review all concurrent medications.

If any of these factors are present, address them first. However, given the patient is on only 50 mcg (a low dose), the most likely explanation is simply inadequate dosing rather than malabsorption or non-compliance.

The Normal Free T4 Paradox

The normal free T4 with markedly elevated TSH is unusual but does not change management. This pattern can occur when:

• The patient has early or partial treatment where peripheral T4 levels normalize before TSH suppression catches up
• There is poor T4 to T3 conversion, requiring higher T4 levels to achieve adequate tissue thyroid hormone effect
• The TSH elevation reflects the body's continued demand for more thyroid hormone despite "normal" T4 levels

Do not be falsely reassured by the normal free T4—the TSH of 54 mIU/L is the definitive indicator that this patient needs more levothyroxine 1. The TSH is the most reliable therapeutic endpoint in primary hypothyroidism 1.

Follow-Up Monitoring

• Recheck TSH and free T4 in 4-8 weeks after the dose increase 1, 2
• Continue dose adjustments in 12.5-25 mcg increments every 4-8 weeks until TSH normalizes 1
• Target TSH should be within the reference range (typically 0.4-4.0 mIU/L) 1

Common Pitfall to Avoid

Do not make small, timid dose adjustments (like increasing by only 12.5 mcg) when TSH is this severely elevated. With a TSH of 54 mIU/L, the patient needs a substantial dose increase. A 25-50 mcg increment is appropriate and will still require reassessment and likely further titration 1. Overly conservative dosing prolongs the patient's hypothyroid state and delays symptom resolution.

If after addressing adherence, timing, and drug interactions, the TSH remains elevated on doses exceeding 200 mcg daily, then consider formal evaluation for malabsorption with a levothyroxine absorption test 1, 3, 4.